ATE22804T1 - Pharmazeutische zusammensetzung. - Google Patents

Pharmazeutische zusammensetzung.

Info

Publication number: ATE22804T1
Authority: AT; Austria
Prior art keywords: pharmaceutical composition; niacin; gamma; administered; compositions
Prior art date: 1982-03-01

Application number

AT83300621T

Other languages

English (en)

Inventor

David Frederick Horrobin

Original Assignee

Efamol Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1982-03-01

Filing date

1983-02-08

Publication date

1986-11-15

1983-02-08 Application filed by Efamol Ltd filed Critical Efamol Ltd

1986-11-15 Application granted granted Critical

1986-11-15 Publication of ATE22804T1 publication Critical patent/ATE22804T1/de

Links

239000008194 pharmaceutical composition Substances 0.000 title abstract 2
HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract 2
PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 abstract 1
239000003833 bile salt Substances 0.000 abstract 1
239000011230 binding agent Substances 0.000 abstract 1
239000008280 blood Substances 0.000 abstract 1
210000004369 blood Anatomy 0.000 abstract 1
235000004626 essential fatty acids Nutrition 0.000 abstract 1
VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 abstract 1
VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 abstract 1
235000020664 gamma-linolenic acid Nutrition 0.000 abstract 1
229960002733 gamolenic acid Drugs 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
229960003512 nicotinic acid Drugs 0.000 abstract 1
235000001968 nicotinic acid Nutrition 0.000 abstract 1
239000011664 nicotinic acid Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/785—Polymers containing nitrogen
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Hematology (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Obesity (AREA)
Bioinformatics & Cheminformatics (AREA)
Diabetes (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Dental Preparations (AREA)
Confectionery (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pyridine Compounds (AREA)

AT83300621T 1982-03-01 1983-02-08 Pharmazeutische zusammensetzung. ATE22804T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB8205935		1982-03-01
EP83300621A EP0087864B1 (de)	1982-03-01	1983-02-08	Pharmazeutische Zusammensetzung

Publications (1)

Publication Number	Publication Date
ATE22804T1 true ATE22804T1 (de)	1986-11-15

Family

ID=10528692

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT83300621T ATE22804T1 (de)	1982-03-01	1983-02-08	Pharmazeutische zusammensetzung.

Country Status (7)

Country	Link
EP (1)	EP0087864B1 (de)
JP (1)	JPS58159414A (de)
AT (1)	ATE22804T1 (de)
AU (1)	AU563273B2 (de)
CA (1)	CA1197784A (de)
DE (1)	DE3366838D1 (de)
IE (1)	IE54556B1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS62106019A (ja) *	1985-11-01	1987-05-16	Terumo Corp	抗高脂血症剤
GB8603621D0 (en) *	1986-02-14	1986-03-19	Habib N	Modifying lipid structure of cell membranes
US4965252A (en) *	1988-06-28	1990-10-23	Hauser-Kuhrts, Inc.	Cholesterol-lowering combination compositions of guar gum and niacin
DE3782255T2 (de) *	1987-12-14	1993-04-22	Amer & Co	Cholestyraminzusammensetzungen und verfahren zu ihrer herstellung.
DE4402379C2 (de) *	1994-01-27	1997-09-25	Lohmann Therapie Syst Lts	Orale Arzneiform mit sauren Wirkstoffen und Verfahren zu ihrer Herstellung
GB9403855D0 (en)	1994-03-01	1994-04-20	Scotia Holdings Plc	Fatty acid derivatives
USRE40546E1 (en) *	1996-05-01	2008-10-21	Scarista, Ltd.	1,3-Propane diol esters and ethers and methods for their use in drug delivery
MY118354A (en) *	1995-05-01	2004-10-30	Scarista Ltd	1,3-propane diol derivatives as bioactive compounds
US6015821A (en) *	1995-05-01	2000-01-18	Horrobin; David Frederick	Nicotinic acid esters and pharmaceutical compositions containing them
GB9724840D0 (en) *	1997-11-26	1998-01-21	Kappa Pharmaceuticals Ltd	Reduced blood cholesterol
CA2436650A1 (en)	2003-08-06	2005-02-06	Naturia Inc.	Conjugated linolenic acid (clnatm) compositions: synthesis, purification and uses
GB0907413D0 (en)	2009-04-29	2009-06-10	Equateq Ltd	Novel methods
US8293790B2 (en)	2011-10-19	2012-10-23	Dignity Sciences Limited	Pharmaceutical compositions comprising DGLA and benzoyl peroxide and methods of use thereof
MX375328B (es)	2014-06-04	2025-03-06	Ds Biopharma Ltd	Composiciones farmacéuticas que comprenden ácido dihomo-gamma-linolénico (dgla) y uso de las mismas
US20210315851A1 (en)	2020-04-03	2021-10-14	Afimmune Limited	Compositions comprising 15-hepe and methods of treating or preventing hematologic disorders, and/or related diseases

1983
- 1983-02-08 DE DE8383300621T patent/DE3366838D1/de not_active Expired
- 1983-02-08 AT AT83300621T patent/ATE22804T1/de not_active IP Right Cessation
- 1983-02-08 EP EP83300621A patent/EP0087864B1/de not_active Expired
- 1983-02-09 IE IE263/83A patent/IE54556B1/en not_active IP Right Cessation
- 1983-02-14 CA CA000421504A patent/CA1197784A/en not_active Expired
- 1983-02-16 AU AU11456/83A patent/AU563273B2/en not_active Ceased
- 1983-02-28 JP JP58032684A patent/JPS58159414A/ja active Pending

Also Published As

Publication number	Publication date
IE54556B1 (en)	1989-11-22
EP0087864A3 (en)	1984-03-21
JPS58159414A (ja)	1983-09-21
EP0087864B1 (de)	1986-10-15
AU1145683A (en)	1983-09-08
DE3366838D1 (en)	1986-11-20
IE830263L (en)	1983-09-01
CA1197784A (en)	1985-12-10
EP0087864A2 (de)	1983-09-07
AU563273B2 (en)	1987-07-02

Similar Documents

Publication	Publication Date	Title
DE3486235D1 (de)	1993-12-02	Fettsäure-Zusammensetzungen.
DE3366838D1 (en)	1986-11-20	Pharmaceutical composition
GR3006068T3 (de)	1993-06-21
NO940277L (no)	1994-07-28	Triglycerider og blandinger av slike
ATE22532T1 (de)	1986-10-15	Pharmazeutische zusammensetzung.
EP0175468A3 (de)	1987-07-22	Eicosanoide zur Verwendung bei der Krebstherapie
ATE22533T1 (de)	1986-10-15	Pharmazeutische zusammensetzung.
DE3778132D1 (de)	1992-05-14	2-beta-substituierte methylpenicillansaeure-derivate und deren salze und ester.
ATE44235T1 (de)	1989-07-15	Verwendung von kupfer und fettsaeulen.
ES474408A1 (es)	1979-10-16	Procedimiento para la obtencion de 1,4-dihidropiridinas con agrupaciones ester sulfurosas
IL92357A0 (en)	1990-07-26	Pharmaceutical compositions containing an antibacterial compound and an absorption enhancing system
EP0302481A3 (de)	1990-08-22	Verwendung von freien Fettsäuren zur Herstellung eines Arzneimittels zur Behandlung von Diabetes mellitus
ATE19855T1 (de)	1986-06-15	Pharmazeutische und diaetetische zusammensetzung.
AU570552B2 (en)	1988-03-17	1,4-dihydropyridine-3-carboxylates and salts thereof
ZA834409B (en)	1985-02-27	1,4-dihydropyridine derivatives in optically active or in racemate form and their production and pharmaceutical compositions
DE2967551D1 (en)	1986-01-16	5(6)-(2-amino-5-thiazoloyl)benzimidazole-2-carbamic acid esters and their salts, their preparation and use, and pharmaceutical compositions containing them
ATE136328T1 (de)	1996-04-15	Glycerophospholipidzubereitung mit erhöhter netzmittelwirkung
ES2051864T3 (es)	1994-07-01	Un procedimiento para preparar una composicion farmaceutica con actividad anti-cancer.
EP0089198A3 (de)	1985-05-22	Nichttoxische Aspirin enthaltende Zusammensetzung
RU94002319A (ru)	1995-12-27	Триглицериды
MX9203376A (es)	1992-08-01	Composiciones farmaceuticas que contienen acidos dicarboxilicos alfa-halogenados.
NO158015C (no)	1988-06-29	Forbindelse for anvendelse ved fremstilling av alfa-substituerte alkansyrer eller estere.

Legal Events

Date	Code	Title	Description
1987-06-15	UEP	Publication of translation of european patent specification
1999-11-15	REN	Ceased due to non-payment of the annual fee